|Videos|January 20, 2021
Role of PARP Inhibition in Recurrent Ovarian Cancer
Author(s)Thomas Herzog, MD
Advertisement
Episodes in this series
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
Spotlighting the Top 10 FDA Oncology Approvals in 2025
2
Ivosidenib Combo Shows Preliminary Activity in IDH1-Mutated AML
3
What’s New in Hematology/Oncology? Discussing the 2025 ASH Annual Meeting
4
Janjigian Provides Perspective on Durvalumab Combo Approval in Gastric/GEJ Cancer
5